Further, CEA silencing by CRISPR/Cas9 knockout also leads to the loss of SLeX expression in two MST3Gal IV cell clones, demonstrating that CEA is a major carrier of this glycan in ST3Gal IV transfected gastric cancer cells (Figure 2C). Here, ST3GAL4 is linked to gastric cancer.